AquaBounty Technologies (NASDAQ:AQB) Issues Earnings Results, Hits Estimates

AquaBounty Technologies (NASDAQ:AQB) released its quarterly earnings results on Tuesday. The company reported ($0.88) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.88), RTT News reports. AquaBounty Technologies had a negative return on equity of 17.81% and a negative net margin of 3,923.57%. The business had revenue of $0.05 million for the quarter, compared to the consensus estimate of $0.10 million. During the same quarter last year, the business posted ($1.60) earnings per share.

AquaBounty Technologies Stock Performance

NASDAQ:AQB opened at $1.10 on Thursday. The company has a market capitalization of $4.25 million, a price-to-earnings ratio of -0.06 and a beta of 1.15. The business has a 50 day moving average of $1.13 and a 200 day moving average of $1.47. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.96 and a quick ratio of 1.96. AquaBounty Technologies has a 1-year low of $0.81 and a 1-year high of $4.03.

About AquaBounty Technologies

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.